# Goldman Sachs' Biotech Investments: 21 Startups in Its Portfolio (2026) > The 21 Biotech startups Goldman Sachs has backed, by stage: $4.2B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/goldman-sachs-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series C and later 8 - [Zymergen](https://millionrounds.com/company/zymergen) - [Beacon Therapeutics](https://millionrounds.com/company/beacon-therapeutics) - [Arcutis Biotherapeutics](https://millionrounds.com/company/arcutis-biotherapeutics) - [Counsyl](https://millionrounds.com/company/counsyl) - [Triveni Bio](https://millionrounds.com/company/triveni-bio) - [TraceLink](https://millionrounds.com/company/tracelink) - [Doctor on Demand](https://millionrounds.com/company/doctor-on-demand) - [Ajax Therapeutics](https://millionrounds.com/company/ajax-therapeutics) ## Stage not reported 5 - [Outcome Health](https://millionrounds.com/company/outcome-health) - [*D* DocPlanner](https://millionrounds.com/company/docplanner) - [Entrada Therapeutics](https://millionrounds.com/company/entrada-therapeutics) - [DrFirst](https://millionrounds.com/company/drfirst) - [Silver Creek Pharmaceuticals](https://millionrounds.com/company/silver-creek-pharmaceuticals) ## Series B 5 - [*VB* Viela Bio](https://millionrounds.com/company/viela-bio) - [Ascletis](https://millionrounds.com/company/ascletis) - [MOMA Therapeutics](https://millionrounds.com/company/moma-therapeutics) - [*R* Rimag](https://millionrounds.com/company/rimag) - [Vicebio](https://millionrounds.com/company/vicebio) ## Series A 3 - [Newleos Therapeutics](https://millionrounds.com/company/newleos-therapeutics) - [Nested Therapeutics](https://millionrounds.com/company/nested-therapeutics) - [*O* Orthomimetics](https://millionrounds.com/company/orthomimetics) ## Segment by segment ### Series C and later 8 startups · $2.2B raised - [**Zymergen**](https://millionrounds.com/company/zymergen) United States $874M - [**Beacon Therapeutics**](https://millionrounds.com/company/beacon-therapeutics) Beacon Therapeutics is a clinical-stage ophthalmic gene therapy company founded in 2023, dedicated to saving and restoring vision United States $247M - [**Arcutis Biotherapeutics**](https://millionrounds.com/company/arcutis-biotherapeutics) Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs. United States $245M - [**Counsyl**](https://millionrounds.com/company/counsyl) Counsyl is a health technology company that offers DNA screening for men, women, and their children. United States $207M - [**Triveni Bio**](https://millionrounds.com/company/triveni-bio) Triveni Bio is a clinical-stage biotechnology company based in Watertown, Massachusetts, founded in 2019 through the merger of Ama United States $180M - [**TraceLink**](https://millionrounds.com/company/tracelink) TraceLink is a leading digital network platform that specializes in the orchestration of the pharmaceutical and life sciences supply chain. United States $174M - [**Doctor on Demand**](https://millionrounds.com/company/doctor-on-demand) Doctor On Demand is a nationwide virtual healthcare provider based in San Francisco, offering 24/7 access to board-certified physi United States $161M - [**Ajax Therapeutics**](https://millionrounds.com/company/ajax-therapeutics) Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies. United States $95M ### Stage not reported 5 startups · $918M raised - [**Outcome Health**](https://millionrounds.com/company/outcome-health) Outcome Health is a prominent healthcare technology company based in Chicago, Illinois, focused on enhancing patient care through United States $600M - [*D* **DocPlanner**](https://millionrounds.com/company/docplanner) Poland $141M - [**Entrada Therapeutics**](https://millionrounds.com/company/entrada-therapeutics) Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases. United States $100M - [**DrFirst**](https://millionrounds.com/company/drfirst) DrFirst provides software solutions for physicians and healthcare providers ranging from HIPAA secure messaging, e-prescribing, and EHR. United States $68M - [**Silver Creek Pharmaceuticals**](https://millionrounds.com/company/silver-creek-pharmaceuticals) Silver Creek Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to developing innovative medicines for patients in need. United States $9.2M ### Series B 5 startups · $938M raised - [*VB* **Viela Bio**](https://millionrounds.com/company/viela-bio) Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases. United States $325M - [**Ascletis**](https://millionrounds.com/company/ascletis) Ascletis is a specialty therapeutics company developing therapeutics for the treatment of cancer and infectious diseases. United States $255M - [**MOMA Therapeutics**](https://millionrounds.com/company/moma-therapeutics) MOMA Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, founded in 2020. United States $150M - [*R* **Rimag**](https://millionrounds.com/company/rimag) Rimag is a Shenzhen-based medical imaging service provider. China $108M - [**Vicebio**](https://millionrounds.com/company/vicebio) Vicebio is a biopharmaceutical company developing next-generation respiratory virus vaccines using the Molecular Clamp technology. United Kingdom $100M ### Series A 3 startups · $189M raised - [**Newleos Therapeutics**](https://millionrounds.com/company/newleos-therapeutics) Newleos Therapeutics is a clinical-stage neuroscience and biotechnology company based in Boston, Massachusetts. United States $94M - [**Nested Therapeutics**](https://millionrounds.com/company/nested-therapeutics) Nested Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021. United States $90M - [*O* **Orthomimetics**](https://millionrounds.com/company/orthomimetics) Orthomimetics develops bio-material products such as Chondromimetic, which is used in treating underlying tissues and bone defects. - $5.0M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Goldman Sachs as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **Goldman Sachs' Fintech portfolio** 85 startups · $20B](https://millionrounds.com/portfolio-maps/goldman-sachs-fintech-portfolio)[Sector portfolio **Goldman Sachs' AI portfolio** 45 startups · $85B](https://millionrounds.com/portfolio-maps/goldman-sachs-ai-portfolio)[Sector portfolio **Goldman Sachs' IT Services portfolio** 22 startups · $2.1B](https://millionrounds.com/portfolio-maps/goldman-sachs-it-services-portfolio)[Sector portfolio **Goldman Sachs' Big Data & Analytics portfolio** 19 startups · $2.6B](https://millionrounds.com/portfolio-maps/goldman-sachs-big-data-analytics-portfolio)[Sector portfolio **Goldman Sachs' Cybersecurity portfolio** 15 startups · $2.4B](https://millionrounds.com/portfolio-maps/goldman-sachs-cybersecurity-portfolio)[Sector portfolio **Goldman Sachs' Software portfolio** 14 startups · $1.5B](https://millionrounds.com/portfolio-maps/goldman-sachs-software-portfolio) ## Raising from investors like Goldman Sachs? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)